This clinical trial is focused on studying the effects of a medication called atorvastatin on patients who are undergoing a specific type of heart surgery known as surgical aortic valve replacement. This surgery involves replacing a damaged heart valve with a new one. The study is particularly interested in a condition called post-operative atrial fibrillation (POAF), which is a common heart rhythm problem that can occur after this type of surgery.
The purpose of the study is to see if taking atorvastatin, a medication that helps lower cholesterol, can reduce the chances of developing POAF after surgery. Participants in the study will take atorvastatin starting at least 7 to 14 days before their surgery and continue taking it until 30 days after the surgery. The study will also look at what happens if patients who have been taking statins, like atorvastatin, stop taking them before the surgery. The effects will be monitored using a device called a Holter monitor, which records heart activity over time.
Throughout the study, researchers will observe the participants for any occurrences of POAF and other potential complications, such as infections or heart-related issues. The study aims to provide valuable insights into how atorvastatin might help manage heart rhythm problems after heart valve surgery and whether stopping statin use before surgery affects the risk of these issues. Participants will be monitored closely to ensure their safety and to gather important data on the effectiveness of the treatment.



Denmark